Showing 1 - 10 of 614
The regional effects of sharing a single currency on bilateral trade with other European Union member states are a contentious question. This paper examines the regional effects on trade of the set up of the euro as a common currency. It takes advantage of a gravity specification of bilateral...
Persistent link: https://www.econbiz.de/10008802371
How does fiscal decentralisation affect the development of a health system? Evidence from health care decentralisation in Europe can offer some insights to the question above. This paper addresses the effects of health care decentralisation in Europe, and reviews some of the key questions on the...
Persistent link: https://www.econbiz.de/10010687969
Persistent link: https://www.econbiz.de/10009152871
The European Union is regarded as a union of diverse territories, but this definition applies to most European Union member states, too. How best should member states manage diversity to maintain the Union? What are the main triggers for autonomy demands in a Union? This article contends that...
Persistent link: https://www.econbiz.de/10010240659
The creation of a single currency is deemed to produce further heterogeneity in regional trade, as regions differ in their exposure to trade with other European countries. It is possible to disentangle two separate effects on bilateral trade, namely the “exchange rate volatility effect”...
Persistent link: https://www.econbiz.de/10009760196
In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...
Persistent link: https://www.econbiz.de/10010477153
Persistent link: https://www.econbiz.de/10012225149
Pharmaceutical parallel trade in the European Union is a large and growing phenomenon, and hope has been expressed that it has the potential to reduce prices paid by health insurance and consumers and substantially to raise overall welfare. In this paper we examine the phenomenon empirically,...
Persistent link: https://www.econbiz.de/10009439525
This paper investigates how regulation impinges on the launch strategies of international pharmaceutical corporations for new molecules and generics across the main OECD markets during 1960-2008. Comprehensive IMS data is used to analyze the international diffusion of 845 molecules from 14...
Persistent link: https://www.econbiz.de/10009439690
While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European Union (EU), or the European Economic Area, little is known about the mechanisms that explain its origin or the role of the distribution chain in exporting and importing...
Persistent link: https://www.econbiz.de/10009439866